Catalyst Capital Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $667K | Hold |
1,712
| – | – | 0.01% | 159 |
|
|
2026
Q1 | $810K | Sell |
1,712
-220
| -11% | -$111K | 0.02% | 145 |
|
|
2025
Q4 | $902K | Sell |
1,932
-212
| -10% | -$98.4K | 0.02% | 144 |
|
|
2025
Q3 | $914K | Sell |
2,144
-530
| -20% | -$205K | 0.02% | 147 |
|
|
2025
Q2 | $1.02M | Sell |
2,674
-492
| -16% | -$177K | 0.02% | 148 |
|
|
2025
Q1 | $1.09M | Sell |
3,166
-198
| -6% | -$63.7K | 0.02% | 139 |
|
|
2024
Q4 | $1.01M | Sell |
3,364
-128
| -4% | -$44.7K | 0.02% | 153 |
|
|
2024
Q3 | $1.42M | Sell |
3,492
-1,606
| -32% | -$588K | 0.03% | 128 |
|
|
2024
Q2 | $1.64M | Sell |
5,098
-900
| -15% | -$292K | 0.04% | 121 |
|
|
2024
Q1 | $2M | Buy |
+5,998
| New | +$1.83M | 0.05% | 118 |
|
|
2023
Q4 | – | Sell |
-4,989
| Closed | -$1.23M | – | 390 |
|
|
2023
Q3 | $1.23M | Sell |
4,989
-533
| -10% | -$146K | 0.03% | 132 |
|
|
2023
Q2 | $1.68M | Buy |
+5,522
| New | +$1.54M | 0.05% | 127 |
|
|
2022
Q3 | – | Sell |
-9,706
| Closed | -$1.63M | – | 342 |
|
|
2022
Q2 | $1.63M | Sell |
9,706
-181
| -2% | -$38.9K | 0.07% | 126 |
|
|
2022
Q1 | $2.48M | Hold |
9,887
| – | – | 0.11% | 116 |
|
|
2021
Q4 | $2.54M | Hold |
9,887
| – | – | 0.12% | 116 |
|
|
2021
Q3 | $2.4M | Sell |
9,887
-4,373
| -31% | -$1.07M | 0.12% | 117 |
|
|
2021
Q2 | $2.95M | Hold |
14,260
| – | – | 0.15% | 103 |
|
|
2021
Q1 | $2.69M | Hold |
14,260
| – | – | 0.15% | 96 |
|
|
2020
Q4 | $2.35M | Hold |
14,260
| – | – | 0.13% | 99 |
|
|
2020
Q3 | $1.78M | Buy |
+14,260
| New | +$1.77M | 0.1% | 108 |
|
|
2018
Q2 | – | Sell |
-600
| Closed | -$58K | – | 518 |
|
|
2018
Q1 | $58K | Sell |
600
-21,720
| -97% | -$2.11M | ﹤0.01% | 288 |
|
|
2017
Q4 | $1.96M | Buy |
22,320
+6,880
| +45% | +$553K | 0.07% | 133 |
|
|
2017
Q3 | $1.23M | Hold |
15,440
| – | – | 0.05% | 155 |
|
|
2017
Q2 | $1.35M | Sell |
15,440
-7,810
| -34% | -$661K | 0.06% | 157 |
|
|
2017
Q1 | $2.07M | Sell |
23,250
-3,825
| -14% | -$319K | 0.1% | 118 |
|
|
2016
Q4 | $2M | Sell |
27,075
-2,550
| -9% | -$191K | 0.13% | 112 |
|
|
2016
Q3 | $2.24M | Buy |
29,625
+16,577
| +127% | +$1.27M | 0.25% | 108 |
|
|
2016
Q2 | $1M | Buy |
13,048
+13,000
| +27,083% | +$1.03M | 0.19% | 134 |
|
|
2016
Q1 | $4K | Sell |
48
-5,745
| -99% | -$401K | ﹤0.01% | 428 |
|
|
2015
Q4 | $392K | Buy |
+5,793
| New | +$404K | 0.06% | 195 |
|
Other funds holding HCA
Catalyst Capital Advisors's HCA Position: Q2 2026 in Review
Catalyst Capital Advisors held its HCA Healthcare (HCA) position steady in Q2 2026 at 1,712 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #159.
Catalyst Capital Advisors first reported a position in HCA in Q4 2015 and has held it in 30 quarters since. The position peaked at $2.95M in Q2 2021. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Catalyst Capital Advisors held 1,712 shares of HCA Healthcare worth $667K as of Q2 2026.
- Catalyst Capital Advisors left its HCA Healthcare share count unchanged in Q2 2026.
- HCA Healthcare made up 0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #159 holding.
- Catalyst Capital Advisors first reported a position in HCA Healthcare in Q4 2015 and has held it in 30 quarters since.
- Catalyst Capital Advisors's HCA Healthcare position peaked at $2.95M in Q2 2021.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.